536
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Hsa_circ_0103232 promotes melanoma cells proliferation and invasion via targeting miR-661/RAB3D

, , , &
Pages 1811-1826 | Received 30 Jul 2021, Accepted 25 Apr 2022, Published online: 13 May 2022

References

  • Davis LE, Shalin SC, Tackett AJ. Current state of melanoma diagnosis and treatment. Cancer Biol Ther. 2019;20(11):1366–1379.
  • Luan W, Ding Y, Yuan H, et al. Long non-coding RNA LINC00520 promotes the proliferation and metastasis of malignant melanoma by inducing the miR-125b-5p/EIF5A2 axis. J Exp Clin Cancer Res. 2020;39(1):96.
  • Zhou WJ, Wang H-Y, Zhang J, et al. NEAT1/miR-200b-3p/SMAD2 axis promotes progression of melanoma. Aging (Albany NY). 2020;12(22):22759–22775.
  • Chen S, Yang Z. Circular RNAs: characteristics, function and role in human cancer. Histol & Histopathol Cell & Mol Biol. 2018;33:887–893.
  • Kristensen LS, Andersen MS, Stagsted LVW, et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691.
  • Vo JN, Cieslik M, Zhang Y, et al. The landscape of circular RNA in cancer. Cell. 2019;176(4):869–881.e13.
  • Zhang X, Zhang J, Zheng K, et al. Long noncoding RNAs sustain high expression levels of exogenous octamer-binding protein 4 by sponging regulatory microRNAs during cellular reprogramming. J Biol Chem. 2019;294(47):17863–17874.
  • Li Z, Deng X, Lan Y. Identification of a potentially functional circRNA-miRNA-mRNA regulatory network in type 2 diabetes mellitus by integrated microarray analysis. Minerva Endocrinology. 2021. DOI:10.23736/S2724-6507.21.03370-8
  • Manvati MKS, Khan J, Verma N, et al. Association of miR-760 with cancer: an overview. Gene. 2020;747:144648.
  • Wang X, Yao Z, Fang L. miR-22-3p/PGC1β suppresses breast cancer cell tumorigenesis via PPARγ. PPAR Res. 2021;2021:1–15.
  • Sun J, Kirichenko DA, Chung JL, et al. Perioperative outcomes of melanoma patients undergoing surgery after receiving immunotherapy or targeted therapy. World J Surg. 2020;44(4):1283–1293.
  • Chen X, Tang Y, Yan J, et al. Circ_0062270 upregulates EPHA2 to facilitate melanoma progression via sponging miR-331-3p. J Dermatol Sci. 2021;103(3):176–182.
  • Chen Z, Kang K, Chen S, et al. Circular RNA circ_0017247 promotes melanoma migration and invasion via targeting miR-145. Eur Rev Med Pharmacol Sci. 2020;24(17):8630.
  • Yang X, Li Y, Liu Y, et al. Novel circular RNA expression profile of uveal melanoma revealed by microarray. Chin J Cancer Res. 2018;30(6):656–668.
  • Dudekula DB, Panda AC, Grammatikakis I, et al. CircInteractome: a web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biol. 2016;13(1):34–42.
  • Jin T, Liu M, Liu Y, et al. Lcn2-derived Circular RNA (hsa_circ_0088732) inhibits cell apoptosis and promotes EMT in glioma via the miR-661/RAB3D axis. Front Oncol. 2020;10:170.
  • Chen X, Gao J, Liang N. DUXAP8 knockdown inhibits the development of melanoma by regulating the miR-3182/NUPR1 pathway. Oncol Lett. 2021;22(1):495.
  • Wang Z, Liu Y. MicroRNA-633 enhances melanoma cell proliferation and migration by suppressing KAI1. Oncol Lett. 2021;21(2):88.
  • Zhao G, Zhang W, Dong P, et al. EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway. Cell Biosci. 2021;11(1). DOI:10.1186/s13578-021-00578-5.
  • Chen L, Wu Q, Xu X, et al. Cancer/testis antigen LDHC promotes proliferation and metastasis by activating the PI3K/Akt/GSK-3β-signaling pathway and the in lung adenocarcinoma. Exp Cell Res. 2021;398(2):112414.
  • Alhasan A, Izuogu OG, Al-Balool HH, et al. Circular RNA enrichment in platelets is a signature of transcriptome degradation. Blood. 2016;127(9):e1.
  • Lu R, Zhang X, Li X, et al. Circ_0016418 promotes melanoma development and glutamine catabolism by regulating the miR-605-5p/GLS axis. Int J Clin Exp Pathol. 2020;13(7):1791–1801.
  • Wei CY, Zhu M-X, Lu N-H, et al. Circular RNA circ_0020710 drives tumor progression and immune evasion by regulating the miR-370-3p/CXCL12 axis in melanoma. Mol Cancer. 2020;19(1):84.
  • Chen J, Zhou X, Yang J, et al. Circ-GLI1 promotes metastasis in melanoma through interacting with p70S6K2 to activate Hedgehog/GLI1 and Wnt/β-catenin pathways and upregulate Cyr61. Cell Death Dis. 2020;11(7):596.
  • Lu J, Li Y. Circ_0079593 facilitates proliferation, metastasis, glucose metabolism and inhibits apoptosis in melanoma by regulating the miR-516b/GRM3 axis. Mol Cell Biochem. 2020;475(1–2):227–237.
  • Liu S, Chen L, Chen H, et al. Circ_0119872 promotes uveal melanoma development by regulating the miR-622/G3BP1 axis and downstream signalling pathways. J Exp Clin Cancer Res. 2021;40(1):66.
  • Li Z, Liu Y-H, Diao H-Y, et al. MiR-661 inhibits glioma cell proliferation, migration and invasion by targeting hTERT. Biochem Biophys Res Commun. 2015;468(4):870–876.
  • Liu F, Cai Y, Rong X, et al. MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer. Mol Cancer. 2017;16(1):122.
  • Zhu T, Yuan J, Wang Y, et al. MiR-661 contributed to cell proliferation of human ovarian cancer cells by repressing INPP5J expression. Biomed Pharmacother. 2015;75:123–128.
  • Lv F, Zheng K, Yu J, et al. MicroRNA-661 expression is upregulated in pancreatic ductal adenocarcinoma and promotes cell proliferation. Oncol Lett. 2018;16(5):6293–6298.
  • Luo Y, Ye G-Y, Qin S-L, et al. High expression of Rab3D predicts poor prognosis and associates with tumor progression in colorectal cancer. Int J Biochem Cell Biol. 2016;75:53–62.
  • Yang J, Liu W, Lu X, et al. High expression of small GTPase Rab3D promotes cancer progression and metastasis. Oncotarget. 2015;6(13):11125–11138.
  • Zhang J, Kong R, Sun L. Silencing of Rab3D suppresses the proliferation and invasion of esophageal squamous cell carcinoma cells. Biomed Pharmacother. 2017;91:402–407.
  • Xie J, Zheng Y, Xu X, et al. Long Noncoding RNA CAR10 contributes to melanoma progression by suppressing miR-125b-5p to Induce RAB3D expression. Onco Targets Ther. 2020;13:6203–6211.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.